Home > Insider Trading > Filing (0001437749-13-000626)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1003642	Impax Laboratories Inc	IPXL	Pharmaceutical Preparations (2834)	650403311

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245186	Z Leslie Benet	C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-14	3,500	$8.00	9,700	No	4	M	Direct
Common Stock	Disposition	2012-08-14	3,500	$24.24	6,200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2012-08-14	3,500	$0.00	3,500	$8.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-05-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	600	Indirect	By The Benet Family Trust

Footnotes

The purpose of this amendment is to (i) report the exercise of a stock option inadvertently omitted from Table I and Table II of the Reporting Person's original Form 4 filed with the Securities and Exchange Commission on August 15, 2012 and (ii) correctly report the number of securities beneficially owned by the Reporting Person following the transactions reported herein. Except as otherwise noted in this Form 4/A, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported.
100% of the shares subject to the option are fully vested and exercisable.